Edgewise Therapeutics Stock Price Patterns
| EWTX Stock | USD 27.57 0.90 3.16% |
Momentum 65
Buy Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.43) | EPS Estimate Current Year (1.60) | EPS Estimate Next Year (1.98) | Wall Street Target Price 38.1667 | EPS Estimate Current Quarter (0.40) |
Using Edgewise Therapeutics hype-based prediction, you can estimate the value of Edgewise Therapeutics from the perspective of Edgewise Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Edgewise Therapeutics using Edgewise Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Edgewise using crowd psychology based on the activity and movement of Edgewise Therapeutics' stock price.
Edgewise Therapeutics Short Interest
An investor who is long Edgewise Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Edgewise Therapeutics and may potentially protect profits, hedge Edgewise Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 17.5293 | Short Percent 0.1043 | Short Ratio 5.04 | Shares Short Prior Month 11.7 M | 50 Day MA 25.0644 |
Edgewise Therapeutics Hype to Price Pattern
Investor biases related to Edgewise Therapeutics' public news can be used to forecast risks associated with an investment in Edgewise. The trend in average sentiment can be used to explain how an investor holding Edgewise can time the market purely based on public headlines and social activities around Edgewise Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Edgewise Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Edgewise Therapeutics.
Edgewise Therapeutics Implied Volatility | 1.16 |
Edgewise Therapeutics' implied volatility exposes the market's sentiment of Edgewise Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Edgewise Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Edgewise Therapeutics stock will not fluctuate a lot when Edgewise Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Edgewise Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Edgewise because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Edgewise Therapeutics after-hype prediction price | USD 28.64 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Edgewise contract
Based on the Rule 16, the options market is currently suggesting that Edgewise Therapeutics will have an average daily up or down price movement of about 0.0725% per day over the life of the 2026-05-15 option contract. With Edgewise Therapeutics trading at USD 27.57, that is roughly USD 0.02 . If you think that the market is fully incorporating Edgewise Therapeutics' daily price movement you should consider acquiring Edgewise Therapeutics options at the current volatility level of 1.16%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Edgewise Therapeutics Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Edgewise Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Edgewise Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Edgewise Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Edgewise Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Edgewise Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Edgewise Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Edgewise Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Edgewise Therapeutics' historical news coverage. Edgewise Therapeutics' after-hype downside and upside margins for the prediction period are 22.05 and 35.23, respectively. We have considered Edgewise Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Edgewise Therapeutics is not too volatile at this time. Analysis and calculation of next after-hype price of Edgewise Therapeutics is based on 3 months time horizon.
Edgewise Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Edgewise Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Edgewise Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Edgewise Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.05 | 6.59 | 0.75 | 0.14 | 10 Events / Month | 7 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
27.57 | 28.64 | 0.60 |
|
Edgewise Therapeutics Hype Timeline
Edgewise Therapeutics is currently traded for 27.57. The entity has historical hype elasticity of 0.75, and average elasticity to hype of competition of 0.14. Edgewise is anticipated to increase in value after the next headline, with the price projected to jump to 28.64 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 0.6%, whereas the daily expected return is currently at 1.05%. The volatility of related hype on Edgewise Therapeutics is about 5108.53%, with the expected price after the next announcement by competition of 27.71. Net Loss for the year was (133.81 M) with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next anticipated press release will be in about 10 days. Check out Edgewise Therapeutics Basic Forecasting Models to cross-verify your projections.Edgewise Therapeutics Related Hype Analysis
Having access to credible news sources related to Edgewise Therapeutics' direct competition is more important than ever and may enhance your ability to predict Edgewise Therapeutics' future price movements. Getting to know how Edgewise Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Edgewise Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GPCR | Structure Therapeutics American | 1.97 | 12 per month | 2.99 | 0.16 | 8.96 | (6.75) | 110.34 | |
| QURE | Uniqure NV | (1.97) | 10 per month | 0.00 | (0.13) | 9.37 | (10.75) | 49.34 | |
| VRDN | Viridian Therapeutics | (0.12) | 9 per month | 1.56 | 0.13 | 5.57 | (2.59) | 16.53 | |
| NUVB | Nuvation Bio | (0.36) | 8 per month | 4.61 | 0.05 | 7.33 | (5.78) | 68.61 | |
| OCUL | Ocular Therapeutix | (0.22) | 12 per month | 0.00 | (0.09) | 6.04 | (5.39) | 36.20 | |
| MESO | Mesoblast | 0.84 | 8 per month | 3.17 | 0.01 | 5.49 | (3.96) | 19.08 | |
| GLPG | Galapagos NV ADR | 0.82 | 3 per month | 1.12 | 0.07 | 2.62 | (1.87) | 7.08 | |
| JANX | Janux Therapeutics | 0.12 | 8 per month | 0.00 | (0.11) | 7.88 | (5.07) | 63.52 | |
| CLDX | Celldex Therapeutics | 0.10 | 9 per month | 0.00 | (0.04) | 6.44 | (5.57) | 13.96 | |
| VERA | Vera Therapeutics | 0.11 | 9 per month | 3.05 | 0.14 | 10.77 | (4.62) | 23.44 |
Edgewise Therapeutics Additional Predictive Modules
Most predictive techniques to examine Edgewise price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Edgewise using various technical indicators. When you analyze Edgewise charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Edgewise Therapeutics Predictive Indicators
The successful prediction of Edgewise Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Edgewise Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Edgewise Therapeutics based on analysis of Edgewise Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Edgewise Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Edgewise Therapeutics's related companies.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Edgewise Stock Analysis
When running Edgewise Therapeutics' price analysis, check to measure Edgewise Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edgewise Therapeutics is operating at the current time. Most of Edgewise Therapeutics' value examination focuses on studying past and present price action to predict the probability of Edgewise Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edgewise Therapeutics' price. Additionally, you may evaluate how the addition of Edgewise Therapeutics to your portfolios can decrease your overall portfolio volatility.